| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Immunocore Holdings plc (NASDAQ: IMCR)
IMCR Technical Analysis
5
| As on 9th Jun 2023 IMCR STOCK Price closed @ 56.99 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 38.24 & Strong Buy for SHORT-TERM with Stoploss of 26.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMCRSTOCK Price
| Open | 58.24 | Change | Price | % |
| High | 58.50 | 1 Day | -0.91 | -1.57 |
| Low | 56.44 | 1 Week | 1.81 | 3.28 |
| Close | 56.99 | 1 Month | -1.80 | -3.06 |
| Volume | 308313 | 1 Year | 24.94 | 77.82 |
| 52 Week High 65.71 | 52 Week Low 18.94 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IMCR Daily Charts |
IMCR Intraday Charts |
Whats New @ Bazaartrend |
IMCR Free Analysis |
|
|
IMCR Important Levels Intraday
| RESISTANCE | 60.96 |
| RESISTANCE | 59.69 |
| RESISTANCE | 58.90 |
| RESISTANCE | 58.11 |
| SUPPORT | 55.87 |
| SUPPORT | 55.08 |
| SUPPORT | 54.29 |
| SUPPORT | 53.02 |
IMCR Forecast April 2024
| 4th UP Forecast | 84.85 |
| 3rd UP Forecast | 75.92 |
| 2nd UP Forecast | 70.39 |
| 1st UP Forecast | 64.87 |
| 1st DOWN Forecast | 49.11 |
| 2nd DOWN Forecast | 43.59 |
| 3rd DOWN Forecast | 38.06 |
| 4th DOWN Forecast | 29.13 |
IMCR Weekly Forecast
| 4th UP Forecast | 66.30 |
| 3rd UP Forecast | 63.31 |
| 2nd UP Forecast | 61.47 |
| 1st UP Forecast | 59.62 |
| 1st DOWN Forecast | 54.36 |
| 2nd DOWN Forecast | 52.51 |
| 3rd DOWN Forecast | 50.67 |
| 4th DOWN Forecast | 47.68 |
IMCR Forecast2024
| 4th UP Forecast | 154.55 |
| 3rd UP Forecast | 123.26 |
| 2nd UP Forecast | 103.92 |
| 1st UP Forecast | 84.58 |
| 1st DOWN Forecast | 29.4 |
| 2nd DOWN Forecast | 10.06 |
| 3rd DOWN Forecast | -9.28 |
| 4th DOWN Forecast | -40.57 |
Immunocore Holdings plc ( NASDAQ USA Symbol : IMCR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMCR Business Profile
Immunocore Holdings Limited, a late-stage biotechnology company, develops immunotherapies for the treatment of oncology, infectious, and autoimmune diseases. The company's lead oncology therapeutic candidate is tebentafusp, which is in a randomized Phase III clinical trial in patients with previously untreated metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung, gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising breast, endometrial, ovarian, and small cell lung cancers; and GSK01 that is in a Phase I clinical trial. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. The company was founded in 1999 and is headquartered in Abingdon, the United Kingdom. Address: 92 Park Drive, Abingdon, United Kingdom, OX14 4RY
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service